Proof of Usefulness Report

Protai

Analysis completed on 1/28/2026

+692
Proof of Usefulness Score
Category Standard

The submission for 'Protai' contains significant inaccuracies (claiming 'everyone' as audience and 'most people' as users), characteristic of low-effort input. However, independent verification confirms Protai is a legitimate, high-value biotechnology company based in Tel Aviv. It has raised approximately $20M in funding (Seed + Extension) from investors like Grove Ventures and Pitango HealthTech to develop an AI-powered proteomics platform for drug discovery. The company has verified traction through hospital partnerships and a growing team (~26 people aligned with input). The score reflects the high real-world utility and verified traction of the actual business, heavily weighted against the poor quality of the submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+230.0
Audience Reach Impact+50.0
Technical Innovation+171.0
Evidence Of Traction+225.0
Market Timing Relevance+90.0
Functional Completeness+2.5
Subtotal+768.5
Usefulness Multiplierx0.90
Final Score+692

Project Details

Project URL
Description
Protaiis in the Life Sciences Tech Industry

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline